Publications Office of the EU
Delivery of medicines - 2 parts - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

Delivery of medicines - 2 parts

  • Published
    25/08/2025
  • Deadline
    29/09/2025
  • Opening of tenders
    29/09/2025
  • Awarded
    04/11/2025
  • Today
    16/09/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Centrum Onkologii Ziemi Lubelskiej im. św. Jana z Dukli
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: PL814 Lubelski
Business sector (Main CPV)
33690000 Various medicinal products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
611,753.25 PLN
Number of lots
2
Tender reference number
COZL/DZP/ED/3411/PN-109/25
Description

The subject of the contract is the supply of medicines. The contract was divided into 2 lots: Part 1 – Treosulfan Part 2 – Immunoglobulin p/human thymocytes

Submission Method
Electronic via:
https://platformazakupowa.pl/transakcja/1162083
Tenders may be submitted
Electronic submission: required
https://platformazakupowa.pl/transakcja/1162083
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
29/09/2025 09:30
Place of performance
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.